Lin C, Lin E, Lane H
Schizophrenia (Heidelb). 2025; 11(1):27.
PMID: 39987274
PMC: 11846841.
DOI: 10.1038/s41537-024-00548-z.
Hazan H, Tayfur S, Zhou B, Li F, Gibbs-Dean T, Karmani S
PLoS One. 2025; 20(2):e0312740.
PMID: 39928579
PMC: 11809850.
DOI: 10.1371/journal.pone.0312740.
Giguere S, Beaudoin M, Dellazizzo L, Phraxayavong K, Potvin S, Dumais A
JMIR Ment Health. 2024; 11:e58499.
PMID: 39602812
PMC: 11612600.
DOI: 10.2196/58499.
De Filippis S, Vita A, Cuomo A, Amici E, Giovanetti V, Lombardozzi G
Ann Gen Psychiatry. 2024; 23(1):43.
PMID: 39501351
PMC: 11536833.
DOI: 10.1186/s12991-024-00531-z.
Pinho L, Lopes M
Port J Public Health. 2024; 40(1):17-25.
PMID: 39469500
PMC: 11320071.
DOI: 10.1159/000524422.
Multivariate Association Between Functional Connectivity Gradients and Cognition in Schizophrenia Spectrum Disorders.
Yu J, Hawco C, Bassman L, Oliver L, Argyelan M, Gold J
Biol Psychiatry Cogn Neurosci Neuroimaging. 2024; .
PMID: 39260567
PMC: 11891086.
DOI: 10.1016/j.bpsc.2024.09.001.
Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial.
Yamanushi A, Shimada T, Koizumi A, Kobayashi M
Biomedicines. 2024; 12(7).
PMID: 39062072
PMC: 11274551.
DOI: 10.3390/biomedicines12071498.
A Systematic Review of the Effect of Stigmatization on Psychiatric Illness Outcomes.
Chukwuma O, Ezeani E, Fatoye E, Benjamin J, Okobi O, Nwume C
Cureus. 2024; 16(6):e62642.
PMID: 39036187
PMC: 11258934.
DOI: 10.7759/cureus.62642.
Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder.
Corbera S, Wexler B, Bell M, Pittman B, Pelphrey K, Pearlson G
Schizophr Res. 2024; 271:1-8.
PMID: 39002525
PMC: 11384336.
DOI: 10.1016/j.schres.2024.07.002.
Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.
Ibragimov K, Keane G, Carreno Glaria C, Cheng J, Llosa A
Cochrane Database Syst Rev. 2024; 7:CD013425.
PMID: 38958149
PMC: 11220909.
DOI: 10.1002/14651858.CD013425.pub2.
Functional phenotypes in schizophrenia spectrum disorders: defining the constructs and identifying biopsychosocial correlates using data-driven methods.
Tang S, Hansel K, Oliver L, Dickie E, Hawco C, John M
Schizophrenia (Heidelb). 2024; 10(1):58.
PMID: 38914577
PMC: 11196713.
DOI: 10.1038/s41537-024-00479-9.
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia.
Boskovic D, Smith-Palmer J, Pohlmann J, Pollock R, Hwang S, Bruhn D
Patient Relat Outcome Meas. 2024; 15:199-217.
PMID: 38911609
PMC: 11192194.
DOI: 10.2147/PROM.S454845.
Factors associated with health-related quality of life in long-stay inpatients with chronic schizophrenia.
Oyama H, Oda K, Matsuo R
PCN Rep. 2024; 1(3):e42.
PMID: 38868685
PMC: 11114288.
DOI: 10.1002/pcn5.42.
The effectiveness of savouring interventions on well-being in adult clinical populations: A protocol for a systematic review.
Cullen K, Murphy M, Di Blasi Z, Bryant F
PLoS One. 2024; 19(4):e0302014.
PMID: 38626110
PMC: 11020756.
DOI: 10.1371/journal.pone.0302014.
Automating the analysis of facial emotion expression dynamics: A computational framework and application in psychotic disorders.
Hall N, Hallquist M, Martin E, Lian W, Jonas K, Kotov R
Proc Natl Acad Sci U S A. 2024; 121(14):e2313665121.
PMID: 38530896
PMC: 10998559.
DOI: 10.1073/pnas.2313665121.
Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis.
Mayer S, Corcoran C, Kennedy L, Leucht S, Bighelli I
Cochrane Database Syst Rev. 2024; 3:CD015331.
PMID: 38470162
PMC: 10929366.
DOI: 10.1002/14651858.CD015331.pub2.
Trajectories and predictors of response to social cognition training in people with schizophrenia: A proof-of-concept machine learning study.
Miley K, Bronstein M, Ma S, Lee H, Green M, Ventura J
Schizophr Res. 2024; 266:92-99.
PMID: 38387253
PMC: 11005939.
DOI: 10.1016/j.schres.2024.02.027.
Cognitive behavioural therapy without medication for schizophrenia.
Bighelli I, Ciray O, Salahuddin N, Leucht S
Cochrane Database Syst Rev. 2024; 2:CD015332.
PMID: 38323679
PMC: 10848293.
DOI: 10.1002/14651858.CD015332.pub2.
Ranking tailoring variables for constructing individualized treatment rules: an application to schizophrenia.
Wu J, Galanter N, Shortreed S, Moodie E
J R Stat Soc Ser C Appl Stat. 2024; 71(2):309-330.
PMID: 38288004
PMC: 10823524.
DOI: 10.1111/rssc.12533.
Hearing Loss in Older People With Schizophrenia: Audiologic Characteristics and Association With Psychosocial Functioning.
Saperstein A, Subhan B, Golub J, Medalia A
Am J Geriatr Psychiatry. 2023; 32(4):489-496.
PMID: 38030420
PMC: 10950537.
DOI: 10.1016/j.jagp.2023.11.002.